Momenta can't do anything about the rumor. The question is whether there is any reason to doubt the confidence that several people at Teva have expressed recently. A quote from r and d made to an Israeli paper-- "We are waiting to receive the approval soon and the chances of receiving it is high." I believe Teva has reason to think this is true.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.